body | Futurist Transhuman News Blog

In a grotesque twist to the online trend of "looksmaxxing," a term referring to male incels looking to maximize their own physical attractiveness, a TikTok user has spent over 160 days working out just a single trapezius muscle.

In daily update videos, the college student, who goes by the fitting online handle TheCrookedMon, showed off the results of his unorthodox "looks minimizing" strategy: a massively imbalanced shoulder muscle diagonally — and unsettlingly — stretching from the left side of his head to his left shoulder.

Why? Besides a modicum of internet clout, we're still not entirely sure.

To get his very particular gains, TheCrookedMon did daily shrugs on his left side only, using a variety of objects, including a dog, a backpack, and a pack of drinks at the grocery store.

Instead of cheering him on, commenters appeared largely concerned for his health.

"Bro you proved your point," one user wrote, with a crying emoji.

"Bro stop please," another comment reads.

Others were more impressed.

"This is literally the biggest flex I've ever seen," one user wrote.

There’s a kid who has only trained one trap for most of a year and it’s one of the most autistic things I’ve ever seen pic.twitter.com/3d0GRbZPKi
— Bill Coyne (@MiloAgonistes) April 11, 2025

The trend became so big, it spawned an entire memecoin, dubbed $TRAPMAN. According to DexScreener, the coin spiked to a value of $0.00003649 — yes, you read that decimal point correctly — when it launched on April 13. Unsurprisingly, the dubious asset crashed almost immediately, wiping out most of its value.

The jury is still out on whether TheCrookedMon could be damaging his body, but chances are he'll be fine in the long run. Researchers have found that primarily focusing on training just one side of the body could still have plenty of benefits for the other side.

It's a particularly pertinent reality for those recovering from an injury or missing part of their body. Research has shown that training just one side could even build muscle mass in an unused, injured limb through the triggering of neural pathways, a phenomenon referred to as the "cross-training effect" or "cross-education."

However, that doesn't mean we condone the kind of eyebrow-raising workout regimen TheCrookedMon chose for himself — there are far better ways to design a unilateral training plan.

In a tongue-in-cheek April 2 video, he attempted to explain why he intentionally sacrificed his looks.

"I was scrolling TikToks in my Ferrari, and I kept getting these looksmaxxing TikToks," he said. "And they were like, 'Do this, do that, you'll look more attractive, you'll get more women."

"And it's like, people have that problem?" he added. "I've the opposite problem. I get so many DMs I don't even have time to get through them all."

"If I have the opposite problem, then I need the opposite solution," TheCrookedMon argued.

Worse things are on the horizon: Over the past month, TheCrookedMan has now started working out just his right leg.

More on the incel community: A Google-Backed AI Startup Is Hosting Chatbots Modeled After Real-Life School Shooters — and Their Victims

The post Horrifying Results as Man Exercises Only One Single Muscle appeared first on Futurism.

A series of new studies showed that taking Ozempic reduced death rates from all causes, which may be a sign that it combats aging.

There's a lot of talk about the diabetes and weight loss drug semaglutide — sold under the brand names Ozempic and Wegovy — being a "miracle" drug, as researchers keep finding health benefits that exceed its originally intended capabilities.

Now, a series of new studies show that people who took semaglutide died at a lower rate from all causes — which, some scientists are now suggesting, could be a sign that the drug actually combats aging itself.

"Semaglutide has far-reaching benefits beyond what we initially imagined," Harlan Krumholz of the Yale School of Medicine said Friday at the European Society of Cardiology Conference 2024, as quoted by the BBC. "It's not just avoiding heart attacks. These are health promoters. It wouldn't surprise me that improving people's health this way actually slows down the aging process."

The studies were conducted as part of the Select trial in the US, which in all followed more than 17,600 people, 45 years of age and older, who were obese or overweight and had cardiovascular disease, but did not have diabetes. Over the course of more than three years, each of these subjects were given semaglutide or a placebo.

The results were stark. The patients who took semaglutide died at a 19 percent lower rate from all causes compared to the placebo group, the studies found, including from infections and cardiovascular issues. Deaths from COVID-19, for example, were reduced by 33 percent.

Semaglutide is a GLP-1 agonist, meaning it mimics the GLP-1 hormone that manages your body's production of insulin. This means that it's effective at managing blood sugar levels, but because the hormone affects your brain's perception of satiety, it can also be used to suppress your appetite and change the way your body processes food.

The drug has blown up as a weight loss treatment, but simultaneously garnered a reputation for treating a host of ailments beyond its officially prescribed uses. Some patients have found themselves cured of their drinking and smoking habits. Meanwhile, studies have linked semaglutide with a lower risk of dementia and have shown that it can halt diabetic kidney disease. It's also been approved to lower the risk of heart disease.

These latest studies further reify the drug's versatility and far-reaching impacts.

"The robust reduction in non-cardiovascular death, and particularly infections deaths, was surprising," Benjamin Scirica, lead author of one of the Select studies, told The Guardian. "These findings reinforce that overweight and obesity increases the risk of death due to many etiologies which can be modified with therapies like semaglutide."

To be sure, some of the glowing press around Ozempic can be a little breathless, and some studies have suggested troubling side effects, such as a potential link to suicidal ideation. But these are tenuous or disputed — and so far, most of the evidence seems to suggest that semaglutide is delivering on its hype.

More on Ozempic: New Study Finds Wegovy Reduces COVID Death Risk By 33 Percent

The post Ozempic Actually Delays Aging, Scientist Claims appeared first on Futurism.

See the article here:
Ozempic Actually Delays Aging, Scientist Claims